{
    "2018-06-04": [
        [
            {
                "time": "",
                "original_text": "[强烈推荐评级]健帆生物(300529)：预计Q2收入增长接近40% 产品放量继续加快",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "Q2收入增长",
                        "40%",
                        "产品放量"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}